Abstract:Stroke is one of the most threatening diseases worldwide, particularly in countries with larger populations; it is associated with high morbidity, mortality and disability rates. As a result, extensive research efforts are being made to address these issues. Stroke can include either hemorrhagic stroke (blood vessel ruptures) or ischemic stroke (blockage of an artery). Whilst the incidence of stroke is higher in the elderly population (≥65), it is also increasing in the younger population. Ischemic stroke accounts for ~85% of all stroke cases. The pathogenesis of cerebral ischemic injury can include inflammation, excitotoxic injury, mitochondrial dysfunction, oxidative stress, ion imbalance and increased vascular permeability. All of the aforementioned processes have been extensively studied, providing insights into the disease. Other clinical consequences observed include brain edema, nerve injury, inflammation, motor deficits and cognitive impairment, which not only cause disabilities obstructing daily life but also increase the mortality rates. Ferroptosis is a type of cell death that is characterized by iron accumulation and increased lipid peroxidation in cells. In particular, ferroptosis has been previously implicated in ischemia-reperfusion injury in the central nervous system. It has also been identified as a mechanism involved in cerebral ischemic injury. The tumor suppressor p53 has been reported to modulate the ferroptotic signaling pathway, which both positively and negatively affects the prognosis of cerebral ischemia injury. The present review summarizes the recent findings on the molecular mechanisms of ferroptosis under the regulation of p53 underlying cerebral ischemia injury. Understanding of the p53/ferroptosis signaling pathway may provide insights into developing methods for improving the diagnosis, treatment and even prevention of stroke.

Targeting p53 for neuroinflammation: New therapeutic strategies in ischemic stroke

Network-Based Approach to Identify Potential Targets and Drugs That Promote Neuroprotection and Neurorepair in Acute Ischemic Stroke

Targeting Neutrophils in Ischemic Stroke: Translational Insights from Experimental Studies

Mechanisms of immune response and cell death in ischemic stroke and their regulation by natural compounds

p53-mediated neuronal cell death in ischemic brain injury

Regulation of the p53‑mediated ferroptosis signaling pathway in cerebral ischemia stroke (Review)

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

Cell polarization in ischemic stroke: molecular mechanisms and advances

Inhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke

Thrombo-Inflammation and Immunological Response in Ischemic Stroke: Focusing on Platelet-Tregs Interaction

Therapeutic strategies targeting the NLRP3‐mediated inflammatory response and pyroptosis in cerebral ischemia/reperfusion injury (Review)

Focus on the role of mitochondria in NLRP3 inflammasome activation: A prospective target for the treatment of ischemic stroke (Review)

Ischemic stroke: From pathological mechanisms to neuroprotective strategies

Targeting PTEN in ischemic stroke: From molecular mechanisms to therapeutic potentials

P53 Inhibition Protects Against Neuronal Ischemia/Reperfusion Injury by the P53/pras40/mtor Pathway

Post-ischemic inflammatory response in the brain: Targeting immune cell in ischemic stroke therapy

New Insight Into Neutrophils: A Potential Therapeutic Target for Cerebral Ischemia

Mechanism of inflammatory response and therapeutic effects of stem cells in ischemic stroke: current evidence and future perspectives

The mechanism of microglia-mediated immune inflammation in ischemic stroke and the role of natural botanical components in regulating microglia: A review

PI3K/AKT signaling and neuroprotection in ischemic stroke: molecular mechanisms and therapeutic perspectives

Potential Immunotherapeutic Targets on Myeloid Cells for Neurovascular Repair after Ischemic Stroke